Russia Healthcare Spendings to Reach 11.2bn Rubles in 2020

27 September 2019

GMP News

The Russian government has approved the draft federal budget for 2019 and the planning period 2020-2021. In 2020, 11.277 billion rubles will be allocated for financing the pharmaceutical and medical industries.

The surplus of the federal budget of the Russian Federation in 2020 will amount to 0.9 trillion rubles, in 2021 – 0.6 trillion rubles, and in 2022 – 0.3 trillion rubles. This is stated in the draft budget for 2020 and for the planning period 2021-2022.

The amount of financing of the state program for the development of healthcare can reach 2.4 trillion rubles. In 2020, it is planned to allocate 841.852 billion rubles for these purposes, in 2021 – 780.421 billion rubles, in 2022 – 785.76 billion rubles. At the same time, 11.277 billion rubles were provided for financing the state program of the pharmaceutical and medical industries in 2020, 11.08 billion rubles in 2021, and 11.087 billion rubles in 2022.

The federal project “Fight against oncological diseases” of the national project “Healthcare” may receive next year about 190 billion rubles. In addition, the amount of funding for the program is planned at 182 billion in 2021 and 186.8 billion rubles in 2022.

Almost 50 billion rubles are planned to be allocated next year for the re-equipment of medical organizations providing medical care to patients with cancer. An information and communication campaign aimed at early detection of cancer and increasing adherence to treatment will receive 200 million rubles in the next three years.

According to the objectives of the national project “Healthcare”, in six years it is planned to reduce mortality from cancer to 185 cases per 100 thousand people. To achieve this goal, it is planned to direct almost 1 trillion rubles. Most of these funds will be used to provide Russians with modern medicines in accordance with international clinical guidelines and treatment protocols.




Read more


Read more

Media Center

Read more